Invus
0 followers
About Invus
Invus is an evergreen equity investor with over $10 billion under management, empowering leaders to transform their industries. They provide the freedom to take risks, capital to reach the prize, and advice to navigate uncharted waters.
Recent News
Recent Deals
Flexiv Raises Growth-Stage Funding From Invus to Accelerate Global Robot Deployment
March 18, 2026
Kailera Therapeutics Secures $600M Series B Funding Led by Bain Capital Private Equity
November 7, 2025
Triana Biomedicines Secures $120M Series B Funding Led by Ascenta Capital and Bessemer
December 3, 2025
Hemab Therapeutics Raises $157M in Series C Led by Sofinnova Partners
October 27, 2025
Ray Therapeutics Closes $125M Series B to Advance Vision‑Restoring Therapies
April 23, 2026